Apollomics shares are trading higher after the company announced it has regained Nasdaq compliance.

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday's after-market session. The company's market cap stands at $4.5 million. As per the news, the Q2 earnings report

Apollomics Announces $10M Private Placement Of Up To 700,001 Class A Ordinary Shares At $15 Per Share, Including $2M Note Conversion By CEO Howard Chen

Apollomics Regains Nasdaq Compliance

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and